Hepatotoxicity due to herbal dietary supplements: Past, present and the future

BJ Gurley, MR McGill, I Koturbash - Food and Chemical Toxicology, 2022 - Elsevier
Dietary supplements (DS) constitute a widely used group of products comprising vitamin,
mineral, and botanical extract formulations. DS of botanical or herbal origins (HDS) …

[HTML][HTML] Weight Regain after Metabolic Surgery: Beyond the Surgical Failure

J Salazar, P Duran, B Garrido, H Parra… - Journal of Clinical …, 2024 - mdpi.com
Patients undergoing metabolic surgery have factors ranging from anatomo-surgical,
endocrine metabolic, eating patterns and physical activity, mental health and psychological …

[HTML][HTML] Impact of Treatment with GLP1 Receptor Agonists, Liraglutide 3.0 mg and Semaglutide 1.0 mg, While on a Waiting List for Bariatric Surgery

MA Rubio-Herrera, S Mera-Carreiro… - Biomedicines, 2023 - mdpi.com
Background: Weight loss before undergoing metabolic and bariatric surgery (MBS) has
been suggested to reduce perioperative complications, although with controversial results …

Consensus on pharmacological treatment of obesity in Latin America

AM Cappelletti, A Valenzuela Montero… - Obesity …, 2024 - Wiley Online Library
A panel of 10 experts in obesity from various Latin American countries held a Zoom meeting
intending to reach a consensus on the use of anti‐obesity medicines and make updated …

Preoperative and early adjuvant weight loss medications in bariatric surgery patients with body mass index over 60 or suboptimal initial response to surgery

JG Cunningham, N Szoka, LE Tabone, S Cox… - Surgery for Obesity and …, 2023 - Elsevier
Background Few studies have examined the adjuvant use of antiobesity medications with
surgery, especially in the pre-and early postoperative periods. Objective Evaluate the impact …

Análise da evolução da composição corporal segmentar em bariátricos com reganho de peso e submetidos à terapêutica farmacológica com Liraglutida

RB Santos - 2021 - repositorio.uvv.br
tá em crescente prevalência e incidência, compreendendo problema de saúde pública
mundial. A cirurgia bariátrica é a terapêutica mais eficaz em pacientes cujo tratamento …

[HTML][HTML] Opiniones y recomendaciones de la Sociedad Argentina de Diabetes. Hemoglobina A1c

MC Maselli, I Llanos, C Lucarelli, C Fenili… - Revista de la …, 2023 - SciELO Argentina
La estandarización de la hemoglobina A1c (HbA1c) permitió en algunos países su uso para
el diagnóstico de la diabetes mellitus (DM) y la prediabetes, además de su empleo en el …

Análise da evolução da composição corporal segmentar em bariátricos com reganho de peso submetidos à terapêutica farmacológica com liraglutida

R Bongestab, TU de Andrade - Research, Society and Development, 2022 - rsdjournal.org
Obesity is a chronic, multifactorial disease, responsible for several morbidities, and bariatric
surgery is an efficient alternative for rapid weight loss. About 20 to 25% of patients, even …

[HTML][HTML] Adyuvancia farmacológica poscirugía metabólica

MA Ackermann - Revista de la Sociedad Argentina de Diabetes, 2022 - revistasad.com
Tratar la diabetes mellitus tipo 2 (DM2) en pacientes con obesidad es un desafío para los
médicos, tanto diabetólogos como cirujanos. La cirugía metabólica (CM) es el tratamiento …